G9a dictates neuronal vulnerability to inflammatory stress via transcriptional control of ferroptosis

Nicola Rothammer,Marcel S. Woo,Simone Bauer,Lars Binkle-Ladisch,Giovanni Di Liberto,Kristof Egervari,Ingrid Wagner,Undine Haferkamp,Ole Pless,Doron Merkler,Jan Broder Engler,Manuel A. Friese
DOI: https://doi.org/10.1126/sciadv.abm5500
IF: 13.6
2022-08-06
Science Advances
Abstract:Neuroinflammation leads to neuronal stress responses that contribute to neuronal dysfunction and loss. However, treatments that stabilize neurons and prevent their destruction are still lacking. Here, we identify the histone methyltransferase G9a as a druggable epigenetic regulator of neuronal vulnerability to inflammation. In murine experimental autoimmune encephalomyelitis (EAE) and human multiple sclerosis (MS), we found that the G9a-catalyzed repressive epigenetic mark H3K9me2 was robustly induced by neuroinflammation. G9a activity repressed anti-ferroptotic genes, diminished intracellular glutathione levels, and triggered the iron-dependent programmed cell death pathway ferroptosis. Conversely, pharmacological treatment of EAE mice with a G9a inhibitor restored anti-ferroptotic gene expression, reduced inflammation-induced neuronal loss, and improved clinical outcome. Similarly, neuronal anti-ferroptotic gene expression was reduced in MS brain tissue and was boosted by G9a inhibition in human neuronal cultures. This study identifies G9a as a critical transcriptional enhancer of neuronal ferroptosis and potential therapeutic target to counteract inflammation-induced neurodegeneration.
multidisciplinary sciences
What problem does this paper attempt to address?